Cargando…

Aptamer based surface plasma resonance assay for direct detection of neuron specific enolase and progastrin-releasing peptide (31-98)

Neuron specific enolase (NSE) and progastrin-releasing peptide (31-98) (ProGRP31-98) are considered as reliable biomarkers of small cell lung cancer (SCLC). Sensitive determinations of NSE and ProGRP31-98 show great significance in disease surveillance, clinical diagnosis, efficacy evaluation and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Linlin, Shen, Kemin, Zhang, Jianbin, Wan, Wenjuan, Cao, Wenjun, Wang, Zhijun, Guo, Chongzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041927/ https://www.ncbi.nlm.nih.gov/pubmed/35495513 http://dx.doi.org/10.1039/d1ra05041a

Ejemplares similares

Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
por: TUTAR, Nuri, et al.
Publicado: (2019)

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
por: Takada, M., et al.
Publicado: (1996)

Instability of Plasma and Serum Progastrin-Releasing Peptide During Repeated Freezing and Thawing
por: Lee, Jae-Eun, et al.
Publicado: (2016)

Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
por: Li, Li, et al.
Publicado: (2020)

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
por: Barchiesi, Vittoria, et al.
Publicado: (2021)

Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy
por: Li, Ming, et al.
Publicado: (2020)

Diagnostic and therapeutic value of progastrin‐releasing peptide on small‐cell lung cancer: A Single‐Center Experience in China
por: Wu, Xiao‐Yuan, et al.
Publicado: (2018)

Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
por: Dong, Juanjuan, et al.
Publicado: (2021)

Targeting progastrin enhances radiosensitization of colorectal cancer cells
por: Kowalski-Chauvel, Aline, et al.
Publicado: (2017)

Association between Serum Progastrin Biomarker Level and Gastric Cancer
por: Amjadi, Omolbanin, et al.
Publicado: (2022)

Acute effects of N‐terminal progastrin fragments on gastric acid secretion in man
por: Goetze, Jens P., et al.
Publicado: (2017)

Plasma progastrin‐releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis‐targeted agents in patients with metastatic castration‐resistant prostate cancer
por: Yashi, Masahiro, et al.
Publicado: (2022)

Enzyme‐linked Immunosorbent Assay of Pro‐gastrin‐releasing Peptide for Small Cell Lung Cancer Patients in Comparison with Neuron‐specific Enolase Measurement
por: Yamaguchi, Ken, et al.
Publicado: (1995)

In vitro selection of DNA aptamers for the development of chemiluminescence aptasensor for neuron-specific enolase (NSE) detection
por: Zheng, Yue, et al.
Publicado: (2019)

Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells
por: Hernández, Carlos, et al.
Publicado: (2014)

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
por: You, Benoit, et al.
Publicado: (2019)

Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
por: Kohli, Manish, et al.
Publicado: (2021)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022)

Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies
por: Zeniya, Satoshi, et al.
Publicado: (2022)

Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma
por: Doucet, L., et al.
Publicado: (2023)

The value of neutrophil gelatinase-associated lipocalin and citrullinated alpha enolase peptide-1 antibody in diagnosis, classification, and prognosis for patients with sepsis
por: Hou, Xiuzhu, et al.
Publicado: (2020)

Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer
por: Lee, Haeyoung, et al.
Publicado: (2021)

Influence of Water Polarization Caused by Phonon Resonance on Catalytic Activity of Enolase
por: Pietkiewicz, Jadwiga, et al.
Publicado: (2021)

The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis
por: Jin, Guangchun, et al.
Publicado: (2017)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

A Community-Based Study of Quality of Life and Depression among Older Adults
por: Cao, Wenjun, et al.
Publicado: (2016)

Progastrin production transitions from Bmi1(+)/Prox1(+) to Lgr5(high) cells during early intestinal tumorigenesis
por: Giraud, J., et al.
Publicado: (2020)

Targeting cancer with peptide aptamers
por: Seigneuric, Renaud, et al.
Publicado: (2011)

Binding Interactions of Peptide Aptamers
por: New, Roger R. C., et al.
Publicado: (2020)

Idiosyncrasies of thermofluorimetric aptamer binding assays
por: Damase, Tulsi Ram, et al.
Publicado: (2019)

Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis
por: Li, Haolong, et al.
Publicado: (2021)

Molecular modelling, docking and interaction studies of human-plasmogen and salmonella enolase with enolase inhibitors
por: Chauhan, Digvijay Singh, et al.
Publicado: (2012)

Structural Characterization of Haemophilus influenzae Enolase and Its Interaction with Human Plasminogen by In Silico and In Vitro Assays
por: Osorio-Aguilar, Yesenia, et al.
Publicado: (2021)

Aphidius ervi Teratocytes Release Enolase and Fatty Acid Binding Protein Through Exosomal Vesicles
por: Salvia, Rosanna, et al.
Publicado: (2019)

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer
por: Soh, Maureen A, et al.
Publicado: (2011)

Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
por: Zhang, Lihong, et al.
Publicado: (2018)

The eleven-year switch of peptide aptamers
por: Colas, Pierre
Publicado: (2008)

Kinetic Exclusion Assay of Biomolecules by Aptamer Capture
por: Smith, Mark H., et al.
Publicado: (2020)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
por: Prieur, Alexandre, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lvevh4m1hjlu6qv0pt7d4tkhno